Revista da Sociedade Brasileira de Medicina Tropical · 2014
Hybrid capture II and PapilloCheck® tests for detection of anal high-risk human papillomavirus.
Сравнительное исследованиеСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Maia Livia Bravo, Marinho Larissa Cardoso, Bocca Anamélia Lorenzetti, Cavalcante Neto Florêncio Figueiredo, Velasco Lara Franciele Ribeiro, Costa Patrícia Godoy Garcia, Carneiro Fabiana Pirani, Oliveira Paulo Gonçalves de
Аннотация
INTRODUCTION: This study evaluated the level of concordance between hybrid capture II (HCII) and PapilloCheck® for the detection of high-risk human papillomavirus (HPV) in anal samples.
METHODS: Anal cell samples collected from 42 human immunodeficiency virus (HIV)+ patients were analyzed.
RESULTS: Considering only the 13 high-risk HPV types that are detectable by both tests, HCII was positive for 52.3% of the samples, and PapilloCheck® was positive for 52.3%. The level of concordance was 80.9% (Kappa = 0.61).
CONCLUSIONS: Good concordance was observed between the tests for the detection of high-risk HPV.
METHODS: Anal cell samples collected from 42 human immunodeficiency virus (HIV)+ patients were analyzed.
RESULTS: Considering only the 13 high-risk HPV types that are detectable by both tests, HCII was positive for 52.3% of the samples, and PapilloCheck® was positive for 52.3%. The level of concordance was 80.9% (Kappa = 0.61).
CONCLUSIONS: Good concordance was observed between the tests for the detection of high-risk HPV.